HPSE and breast carcinoma: ,14,17,18 Interestingly, knockdown (KD) of BPTF in breast cancer cells leads to a reduction in heparanase (HPSE) expression, thereby compromising HPSE’s ability to cleave heparan sulfate proteoglycans (HSPGs), which serve as NCR ligands on the surface of tumor cells.12